Clinical significance of donor-specific anti-HLA-DR51/52/53 antibodies for antibody-mediated rejection in kidney transplant recipients
Background : The presence of donor-specific antibodies (DSAs) to human leukocyte antigen (HLA) increases the risk of antibody-mediated rejection (ABMR) after kidney transplantation (KT).However, the clinical relevance of anti-HLA-DR51/52/53 antibodies remains unclear because of their weak antigen expression.This study evaluated the association betw